Middle East Rhythm Management Medical Device Market 2024-2030

    In Stock





    Pacemakers, cardiac resynchronization treatment, implanted cardioverter defibrillators, and loop recorders have all evolved and been more widely used during the previous decade. General practitioners are becoming more involved in the monitoring and care of patients who use these devices.


    This article’s goal is to offer an overview of various cardiac rhythm management devices, including their purpose, implant method, post-procedural care, possible problems, and follow-up. They also give practical advice for patients on driving, exercise, sexual intimacy, and electromagnetic interference precautions.


    Cardiac rhythm management devices provide a variety of roles, such as bradycardia pacing, arrhythmia monitoring, cardiac resynchronisation for heart failure, defibrillation, and anti-tachycardia pacing for tachyarrhythmias. Concerns about potential device-related issues should be raised with the physician who will be implanting the device. 


    During the post-implant recovery period, Patients who use cardiac rhythm management devices can live normal, active lifestyles. However, extreme caution should be used in some situations, such as while working near appliances that emit electromagnetic interference. Future advancements will shift away from transvenous leads and towards leadless designs with modular combinations of different components based on the purpose required.


    Heart Rhythm Management is a method in which an implanted device uses electrical pulses to manage both rapid and slow heart rhythms.


    An implanted cardioverter defibrillator (ICD) is a device that is placed in the body of a patient to assist manage the cardiac rhythm. ICDs are incredibly successful at halting severe arrhythmias and are the most effective treatment for ventricular fibrillation, which is the leading cause of sudden cardiac death. The ICD continually monitors the cardiac rhythm and sends a pacemaker shock if it becomes too sluggish. If the heartbeat becomes dangerously rapid, the ICD can give a life-saving shock that restores the heartbeat to normal.


    The heart contains a natural pacemaker that controls electrical impulses throughout the body.The sinoatrial node is the name given to this natural pacemaker. However, when the sinoatrial node fails to function effectively, an artificial pacemaker is required to regulate the heart’s rhythm. An implanted pacemaker constantly monitors the heart’s rhythm and sends electrical impulses to stimulate the heart if it beats too slowly or unevenly.


    Bi-ventricular devices stimulate both the left and right ventricles at the same time, resynchronizing the heart and greatly improving the heart’s ability to circulate blood throughout the body.




    infographic:Middle East Rhythm Management Medical Device Market , Middle East Rhythm Management Medical Device Market Size, Middle East Rhythm Management Medical Device Market Trend, Middle East Rhythm Management Medical Device Market ForeCast, Middle East Rhythm Management Medical Device Market Risks, Middle East Rhythm Management Medical Device Market Report, Middle East Rhythm Management Medical Device Market Share

    The Middle East Rhythm Management Medical Device Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.




    Sorin Group (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, and Orange Business, a leading global communications solutions integrator, launched today in several European countries SMARTVIEW, a remote monitoring solution for patients with implanted cardiac rhythm management (CRM) devices.


    Healthcare practitioners may now obtain critical cardiac data and alarm messages from Sorin’s implanted PARADYM RF devices while the patient is at home using the SMARTVIEW remote monitoring system. 


    The clever patented features incorporated in Sorin’s CRM devices, when combined with remote data transmission, provide expanded diagnostic capabilities and early identification of cardiac disease progression for improved patient management.


    For patients, the SMARTVIEW remote monitoring system can save the amount of time they spend commuting to their clinic for periodic device maintenance.


    A dedicated helpdesk powered by Orange Business and Sorin facilitates the straightforward installation of the user-friendly SMARTVIEW remote monitoring device at the patient’s home.


    This innovative technical set-up support, developed using global best practices, gives patients peace of mind while relieving healthcare professionals of the installation effort.


    Through this collaboration, they have been able to develop an easy-to-use, secure remote monitoring solution for physicians and patients alike that makes use of Sorin’s intelligent device features.


    The addition of this service to Sorin’s increasing portfolio of revolutionary implanted cardiac treatments targeted to save lives and relieve patient symptoms is a significant step forward.


    SMARTVIEW makes use of Orange Business’s worldwide, a scalable e-health platform, which is underpinned by the Orange network’s global reach. A healthcare clinician can gain crucial clinical information by using aOrange’s strong in-house e-health skills, e-health systems integration knowledge, and substantial machine-to-machine (M2M) capabilities enable this platform.


    Orange Business has established substantial competence in the creation and deployment of e-health systems that enable remote monitoring and assessment of chronic diseases in the increasing field of remote patient care.


    Remote monitoring is intended to improve patient follow-up treatment by electronically transferring data from patients implanted cardiac devices to their physicians.


    Using this crucial information, healthcare practitioners can spot possible health problems before they become life-threatening and give prompt treatment. This might lessen the need for hospitalization while also improving patients quality of life.


    Patients who use CRM devices must have frequent check-ups with their doctors to verify that their gadgets are working correctly.The proper treatment is being administered. Managing an expanding number of CRM-implanted patients, as well as the associated follow-up, is becoming increasingly difficult for doctors.


    Remote monitoring systems, which provide doctors access to detailed cardiac data captured by the implanted device while the patient is at home, are a big step forward in patient care.



    • Abbott
    • Boston Scientific
    • Biotronik
    • Lepu Medical Technology
    • Sorin and Orange


    1. How many  Rhythm Management Medical Devices   are manufactured per annum in the Middle East? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Middle East  Rhythm Management Medical Device   and key vendor selection criteria
    3. Where is the Rhythm Management Medical Device  manufactured? What is the average margin per unit?
    4. Market share of Middle East  Rhythm Management Medical Device   market  manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Middle East  Rhythm Management Medical Device   in-house
    6. 5 key predictions for next 5 years in Middle East  Rhythm Management Medical Device   market
    7. Average B-2-B  Rhythm Management Medical Device market price in all segments
    8. Latest trends in  Rhythm Management Medical Device market, by every market segment
    9. The market size (both volume and value) of the  Rhythm Management Medical Device   market in 2024-2030 and every year in between?
    10. Production breakup of  Rhythm Management Medical Device   market, by suppliers and their OEM relationship
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2024-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2024-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop